Effects of Bioactive Glass Scaffold and BMP-2 in Segmental Defects by Liu, Wai-Ching et al.
Effects of Bioactive Glass Scaffold and BMP-2 in Segmental Defects 
Wai-Ching Liu1, Irina S. Robu1, Ming C. Leu2, Mariano Valez3, Tien-Min Chu1  
1 Department of Restorative Dentistry, Indiana University School of Dentistry; 2 Department of 
Mechanical and Aerospace Engineering, Missouri University of Science and Technology; 3Mo-Sci 
Corporation 
  
Reconstruction of segmental defects in the load-bearing area has long been a challenge in orthopaedics. 
We have demonstrated the feasibility of a biodegradable load-bearing scaffold fabricated from 
poly(propylene fumarate)/tricalcium phosphate (PPF/TCP) loaded with bone morphogenetic protein-2 
(BMP-2) to successfully induce healing in those defects. However, there is limited osteoconduction 
observed with the PPF/TCP scaffold itself.  Furthermore, a recent review on BMP-2 revealed greater risks 
in radiculities, ectopic bone formation, osteolysis and poor global outcome in association with the use of 
BMP-2 for spinal fusion. The aims of this study were to evaluate the potential use of a more 
osteoconductive material 13-93 bioactive glass and the potential side effects of locally delivered BMP-2 
on adjacent bones. 13-93 glass scaffolds were fabricated by indirect selective laser sintering and 
implanted into critical size defects created in rat right femurs with and without 10 micrograms of BMP-2. 
The X-ray and micro-CT results showed that bridging callus was found as soon as 3 weeks and 
progressed gradually in the BMP group while minimal bone formation was observed in the control group. 
As expected, stiffness, peak load and energy to break of the BMP group were all higher than the control 
group. Higher healing rates in the 13-93 group was found compared to the healing rate in PPF/TCP group 
evaluated in the past indicating a more osteoconductive nature of the 13-93 scaffolds. The scaffolds of 
both control and BMP groups were partially degraded after 15 weeks as seen in the histological 
images. For the effects of local BMP-2 delivery to adjacent bones, no statistical difference in the 
bone area, mineral content and mineral density was found between control and BMP groups. In 
conclusion, a 13-93 bioactive glass scaffold with local BMP-2 delivery has been demonstrated 
for its potential application in treating large bone defects.  
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